Esami Citologici: Differenziare i Tumori Polmonari

The cytological examination begins with proper sample collection using various techniques.Bronchoscopy with bronchial lavage allows direct visualization and sampling of the airways.Transbronchial needle aspiration, or TBNA, uses a specialized needle to collect samples through the bronchial wall.CT-guided biopsy provides precise targeting of lesions using computed tomography imaging.After collection, samples undergo careful preparation to preserve cellular morphology.The samples are processed through specific fixation and staining techniques.These include Papanicolaou staining, which highlights nuclear details, and May-Grünwald-Giemsa, which provides excellent cytoplasmic detail.Proper sample preparation is crucial for preserving cellular morphology and ensuring accurate evaluation.These carefully prepared samples will now be ready for detailed morphological analysis.Nell'analisi microscopica delle cellule tumorali, osserviamo prima una cellula normale come riferimento.Le cellule tumorali mostrano caratteristiche distintive che le differenziano dalle cellule normali.Esistono quattro principali tipi di carcinoma polmonare, ciascuno con caratteristiche morfologiche uniche.Il carcinoma a piccole cellule, o SCLC, presenta cellule di piccole dimensioni con nuclei molto densi e cromatina finemente granulare.L'adenocarcinoma mostra cellule più grandi con nucleoli prominenti e un pattern di cromatina irregolare.Il carcinoma squamoso è caratterizzato da cellule poligonali con bordi ben definiti e cromatina grossolana.Infine, il carcinoma a grandi cellule presenta cellule di grandi dimensioni con nuclei pleomorfi e nucleoli evidenti.La corretta identificazione di queste caratteristiche morfologiche è fondamentale per una diagnosi accurata.Modern cytological examination incorporates advanced molecular techniques to identify specific markers.Key markers like TTF-1, p63, and EGFR mutations are analyzed using immunocytochemistry.The immunocytochemistry process involves applying specific antibodies that bind to these markers.Molecular analysis examines genetic mutations, particularly in the EGFR gene, which can influence treatment choices.Different types of tumors respond differently to various treatments based on their molecular profile.The precision of cytological diagnosis directly influences treatment strategy and patient prognosis.